Similar articles for PMID: 28212541

Year	Number of Results
2004	1
2009	7
2010	6
2011	9
2012	6
2013	7
2014	12
2015	15
2016	16
2017	6
2018	10
2019	7
2020	6
2021	4
2022	1
2023	5
2024	0

1

Analysis of variability in high throughput screening data: applications to melanoma cell lines and drug responses.

Ding KF, Finlay D, Yin H, Hendricks WPD, Sereduk C, Kiefer J, Sekulic A, LoRusso PM, Vuori K, Trent JM, Schork NJ. Ding KF, et al. Oncotarget. 2017 Apr 25;8(17):27786-27799. doi: 10.18632/oncotarget.15347. Oncotarget. 2017. PMID: 28212541 Free PMC article.

2

A rapid and affordable screening platform for membrane protein trafficking.

Snyder JC, Pack TF, Rochelle LK, Chakraborty SK, Zhang M, Eaton AW, Bai Y, Ernst LA, Barak LS, Waggoner AS, Caron MG. Snyder JC, et al. BMC Biol. 2015 Dec 17;13:107. doi: 10.1186/s12915-015-0216-3. BMC Biol. 2015. PMID: 26678094 Free PMC article.

3

Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.

Clare RH, Cook DA, Johnston KL, Ford L, Ward SA, Taylor MJ. Clare RH, et al. J Biomol Screen. 2015 Jan;20(1):64-9. doi: 10.1177/1087057114551518. Epub 2014 Oct 2. J Biomol Screen. 2015. PMID: 25278497

4

Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations.

Friedman AA, Xia Y, Trippa L, Le LP, Igras V, Frederick DT, Wargo JA, Tanabe KK, Lawrence DP, Neuberg DS, Flaherty KT, Fisher DE. Friedman AA, et al. Clin Cancer Res. 2017 Aug 15;23(16):4680-4692. doi: 10.1158/1078-0432.CCR-16-3029. Epub 2017 Apr 26. Clin Cancer Res. 2017. PMID: 28446504 Free PMC article.

5

Enhancing reproducibility in cancer drug screening: how do we move forward?

Hatzis C, Bedard PL, Birkbak NJ, Beck AH, Aerts HJ, Stem DF, Shi L, Clarke R, Quackenbush J, Haibe-Kains B. Hatzis C, et al. Cancer Res. 2014 Aug 1;74(15):4016-23. doi: 10.1158/0008-5472.CAN-14-0725. Epub 2014 Jul 11. Cancer Res. 2014. PMID: 25015668 Free PMC article. Review.

6

A High Throughput Screen with a Clonogenic Endpoint to Identify Radiation Modulators of Cancer.

Gomes NP, Frederick B, Jacobsen JR, Chapnick D, Su TT. Gomes NP, et al. Radiat Res. 2023 Feb 1;199(2):132-147. doi: 10.1667/RADE-22-00086.1. Radiat Res. 2023. PMID: 36583948 Free PMC article.

7

MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning.

Buterez D, Janet JP, Kiddle SJ, Liò P. Buterez D, et al. J Chem Inf Model. 2023 May 8;63(9):2667-2678. doi: 10.1021/acs.jcim.2c01569. Epub 2023 Apr 14. J Chem Inf Model. 2023. PMID: 37058588 Free PMC article.

8

Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.

Elkins RC, Davies MR, Brough SJ, Gavaghan DJ, Cui Y, Abi-Gerges N, Mirams GR. Elkins RC, et al. J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):112-22. doi: 10.1016/j.vascn.2013.04.007. Epub 2013 May 5. J Pharmacol Toxicol Methods. 2013. PMID: 23651875 Free PMC article.

9

Open access high throughput drug discovery in the public domain: a Mount Everest in the making.

Roy A, McDonald PR, Sittampalam S, Chaguturu R. Roy A, et al. Curr Pharm Biotechnol. 2010 Nov;11(7):764-78. doi: 10.2174/138920110792927757. Curr Pharm Biotechnol. 2010. PMID: 20809896 Free PMC article. Review.

10

A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons.

Sridharan B, Hubbs C, Llamosas N, Kilinc M, Singhera FU, Willems E, Piper DR, Scampavia L, Rumbaugh G, Spicer TP. Sridharan B, et al. Sci Rep. 2019 Jun 21;9(1):9000. doi: 10.1038/s41598-019-45265-1. Sci Rep. 2019. PMID: 31227747 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year